-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Pear Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2021 to Q4 2022.
- Pear Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2022 was $31.7M, a 10.8% decline year-over-year.
- Pear Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2022 was $136M, a 23.8% increase year-over-year.
- Pear Therapeutics, Inc. annual Costs and Expenses for 2022 was $136M, a 23.8% increase from 2021.
- Pear Therapeutics, Inc. annual Costs and Expenses for 2021 was $110M, a 27.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)